Glycogen synthase kinase 3 (gsk-3) and its inhibitors: drug discovery and development
Éditeur :
John Wiley & Sons Inc
ISBN :
9780471770015
Date de publication :
3 nov. 2006
Dimensions :
24,3 x 16,1 x 2,4 cm
Poids :
658 g
Langue :
Anglais
Pays d'origine :
USA
GSK-3 is a promising drug target that has been extensively tested, and shown great potential for treatment of diseases that have no current effective treatment - like Alzheimer's, bipolar disorder, and cancer.